Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05ECA
|
||||
| Former ID |
DIB009583
|
||||
| Drug Name |
LJM716
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Phase 1/2 | [524764] | ||
| Company |
Novartis pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | Receptor protein-tyrosine kinase erbB-3 | Target Info | [532451] | ||
| NetPath Pathway | TNFalpha Signaling Pathway | ||||
| PANTHER Pathway | Cadherin signaling pathway | ||||
| EGF receptor signaling pathway | |||||
| Pathway Interaction Database | ErbB2/ErbB3 signaling events | ||||
| ErbB receptor signaling network | |||||
| a6b1 and a6b4 Integrin signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.